Skip to main content

Table 1 Clinical data of pancreatic adenocarcinoma patients

From: Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

Characteristics

Value

Number of patients

94

Males/Females

44/50

Mean Age (SD), years

60 (10)

Subjects with follow-up data available

91

Censored subjects (Drop-outs)

9 (6)

Surgery

n

Resected

21

Not resected

 

   Palliative surgery

22

   Explorative surgery

7

   Not operated

41

Stage

n

I (T1,2 N0 M0)

2

II (T3 N0 M0 or T1,2,3 N1 M0)

21

III (T4 anyN M0)

34

IVB (anyT anyN M1)

34

Follow-up from diagnosis, median (25 th -75 th percentiles)

Months

Overall

10.5 (5.3-18.5)

Resected (n = 21)

22.7 (13.7-31.8)

Not resected (n = 70)

7.9 (5.0-15.5)